当前位置:首页 - 行情中心 - 普洛药业(000739) - 财务分析

普洛药业

(000739)

  

流通市值:158.62亿  总市值:158.68亿
流通股本:11.69亿   总股本:11.69亿

普洛药业(000739)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润2.49亿元,每股收益0.21元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益699855.12万元,未分配利润538185.11万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产1270854.10万元,负债570998.98万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入2,730,189,121.9712,021,863,029.219,290,220,207.766,428,714,752.29
营业总成本2,490,659,565.2810,858,989,886.758,295,069,270.455,651,769,473.26
营业利润298,437,200.121,212,070,903.261,023,122,464.97740,442,857.06
利润总额297,471,282.941,203,290,373.011,019,844,330.67738,504,086.78
净利润248,576,261.581,030,846,722.3869,388,123.84624,645,137.35
其他综合收益91,753.6610,713,506.83,571,372.34874,296.24
综合收益总额248,668,015.241,041,560,229.1872,959,496.18625,519,433.59
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计8,228,646,015.778,186,761,774.668,782,088,664.29,053,464,655.76
非流动资产合计4,479,894,940.954,542,246,835.54,557,277,677.884,461,792,726.72
资产总计12,708,540,956.7212,729,008,610.1613,339,366,342.0813,515,257,382.48
流动负债合计5,466,974,634.365,742,629,852.136,476,686,297.596,963,798,044.67
非流动负债合计243,015,127.4236,495,578.31274,902,708.89210,195,927.51
负债合计5,709,989,761.765,979,125,430.446,751,589,006.487,173,993,972.18
归属于母公司股东权益合计6,990,603,683.936,741,964,785.166,579,848,258.666,333,267,755.69
股东权益合计6,998,551,194.966,749,883,179.726,587,777,335.66,341,263,410.3
负债和股东权益合计12,708,540,956.7212,729,008,610.1613,339,366,342.0813,515,257,382.48
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计2,227,671,600.3910,411,469,786.978,083,217,866.855,574,563,859.14
经营活动现金流出小计2,242,665,069.559,202,716,103.966,917,508,752.014,593,782,584.66
经营活动产生的现金流量净额-14,993,469.161,208,753,683.011,165,709,114.84980,781,274.48
投资活动现金流入小计271,293,102.69898,626,068.92243,447,417.3532,730,495.81
投资活动现金流出小计362,663,790.841,296,637,801.32607,985,493.56253,997,841.79
投资活动产生的现金流量净额-91,370,688.15-398,011,732.4-364,538,076.21-221,267,345.98
筹资活动现金流入小计296,900,0001,388,885,064.791,005,505,050530,505,050
筹资活动现金流出小计328,296,306.271,971,036,445.911,538,035,740.541,008,803,204.62
筹资活动产生的现金流量净额-31,396,306.27-582,151,381.12-532,530,690.54-478,298,154.62
汇率变动对现金及现金等价物的影响3,246,242.9338,368,228.834,431,426.1331,181,409.14
现金及现金等价物净增加额-134,514,220.65266,958,798.32273,071,774.22312,397,183.02
期末现金及现金等价物余额2,594,930,339.412,729,444,560.062,735,557,535.962,774,882,944.76
最新报告期:2025-04-18
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
国信证券彭思宇0.961.071.202025-04-18
太平洋周豫0.991.131.322025-04-17
招商证券侯彪,梁广楷,许菲菲0.971.101.312025-03-18
太平洋周豫0.991.131.322025-03-17
浙商证券孙建,盖文化,郭双喜1.001.131.362025-03-17
TOP↑